@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP182184.RACMzWCNUoFO1N3IS8XyxSRwbrPUjNo14SBfHJkWrhGHA130_head { this: np:hasAssertion dgn-np:NP182184.RACMzWCNUoFO1N3IS8XyxSRwbrPUjNo14SBfHJkWrhGHA130_assertion; np:hasProvenance dgn-np:NP182184.RACMzWCNUoFO1N3IS8XyxSRwbrPUjNo14SBfHJkWrhGHA130_provenance; np:hasPublicationInfo dgn-np:NP182184.RACMzWCNUoFO1N3IS8XyxSRwbrPUjNo14SBfHJkWrhGHA130_publicationInfo; a np:Nanopublication . dgn-np:NP182184.RACMzWCNUoFO1N3IS8XyxSRwbrPUjNo14SBfHJkWrhGHA130_assertion a np:Assertion . dgn-np:NP182184.RACMzWCNUoFO1N3IS8XyxSRwbrPUjNo14SBfHJkWrhGHA130_provenance a np:Provenance . dgn-np:NP182184.RACMzWCNUoFO1N3IS8XyxSRwbrPUjNo14SBfHJkWrhGHA130_publicationInfo a np:PublicationInfo . } dgn-np:NP182184.RACMzWCNUoFO1N3IS8XyxSRwbrPUjNo14SBfHJkWrhGHA130_assertion { miriam-gene:7124 a ncit:C16612 . lld:C0041296 a ncit:C7057 . dgn-gda:DGNb363fe2f47c81a9cbed3f25ad935e6ff sio:SIO_000628 miriam-gene:7124, lld:C0041296; a sio:SIO_001121 . } dgn-np:NP182184.RACMzWCNUoFO1N3IS8XyxSRwbrPUjNo14SBfHJkWrhGHA130_provenance { dgn-np:NP182184.RACMzWCNUoFO1N3IS8XyxSRwbrPUjNo14SBfHJkWrhGHA130_assertion dcterms:description "[Tetramer staining showed that (1) by direct staining of single sample and flow cytometric analyses, detection of tetramer-positive CD4(+) T cells ranged from 0.1% to 8.8% (median 0.67% in tetramer 1 and 0.5% in tetramer 2), 0.1 to 10.7% (0.74% and 0.71%), 0.02 to 2.2% (0.25% and 0.25%), 0.02 to 0.48% (0.2% and 0.2%) and most at under 0-0.2% (0.2% and 0.16%) in the initial pulmonary TB (PTB) patients' blood, pleural fluid (PLF) of initial tuberculous pleuritis patients, non-TB patients' blood, healthy donors' blood and umbilical cord blood, respectively; significantly higher levels of CD4(+) T cells were detected in samples of TB patients than in three control donor groups; (2) by direct staining of time point TB samples and flow cytometric analyses, along with TB symptom amendment at day 60, tetramer-positive CD4(+) T cells began to decrease, until after 90-120 days, reached and kept at a relatively low even normal level about at 0.03-0.3%; (3) by enrichment approach, at least 10-fold increased memory tetramer-positive CD4(+) T cells were seen; (4) by in situ staining, tetramer-positive, IFN-γ-producing and/or TNF-α-producing CD4(+) T cells in the lymph node and lung granuloma and cavernous tissues of TB patients could be determined.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:21281984; prov:wasDerivedFrom dgn-void:befree-20140225; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20140225 pav:importedOn "2014-02-25"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP182184.RACMzWCNUoFO1N3IS8XyxSRwbrPUjNo14SBfHJkWrhGHA130_publicationInfo { this: dcterms:created "2014-10-02T12:33:38+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetrdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v2.1.0.0" . dgn-void:disgenetrdf pav:version "v2.1.0" . }